Development and Feasibility Testing of Digital Theory-based Pursed Lip Breathing in Stable Patients With COPD
1 other identifier
interventional
15
1 country
1
Brief Summary
The goal of this pre-post design clinical trial is to develop a digital, theory-based Pursed Lip Breathing intervention protocol software system installed on smartphones (DT-PLB) and to preliminarily evaluate its feasibility and effects in stable Chronic Obstructive Pulmonary Disease (COPD). The main objectives are:
- 1.To develop a digital, theory-based Pursed Lip Breathing intervention protocol software system installed on smartphones for managing breathing exercises in stable COPD patients.
- 2.To pilot the methodological procedures of the pre-post study.
- 3.To determine the recruitment rate, retention rate, attrition rate, and software usage compliance during the subject recruitment and follow-up process of the pre-post study.
- 4.To evaluate the perception and satisfaction of COPD patients using the DT-PLB.
- 5.To preliminarily examine the effects of using the DT-PLB intervention on COPD patients, including the six-minute walking test, FEV1% predicted, FEV1/FVC, mMRC scale, COPD assessment test scale, and health points.
- 6.To identify any potential adverse events associated with the implementation of DT-PLB.
- 7.Register a personal account on the DT-PLB software.
- 8.Acquire knowledge and skills related to Pursed Lip Breathing by watching instructional videos.
- 9.Practice Pursed Lip Breathing for 10 minutes per session, three times daily for eight weeks, as per reminders and guidance provided by the software.
- 10.Earn health points by completing specific actions as instructed.
- 11.Optionally post individual texts on the peer forum for peer support within the DT-PLB software.
- 12.Complete two outcome assessments as scheduled.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2023
CompletedFirst Posted
Study publicly available on registry
October 2, 2023
CompletedStudy Start
First participant enrolled
October 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2024
CompletedOctober 2, 2023
September 1, 2023
6 months
September 22, 2023
September 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Recruitment rate
The number of participants who participate in the study divided by the number of participants eligible for participation
From baseline (T1) to the completion of the 8-week intervention (T2)
Retention rate
The number of subjects who complete the study divided by the number of subjects who participate in the study
From baseline (T1) to the completion of the 8-week intervention (T2)
Attrition rate
The number of subjects who drop out after participation divided by the number of subjects who participate in the study
From baseline (T1) to the completion of the 8-week intervention (T2)
Software usage Compliance
The compliance rate is one of compliance outcomes, reflecting the level of patient engagement in the intervention. Overall compliance will be defined as the compliance averaged in all patients. Compliance rate = (actual number of participation in the intervention/planned number of sessions)x 100%. In addition, minutes-consuming recorded on the software for participants during the research will be used to complement outcome measures of compliance.
Immediately after completion of the 8-week intervention
Adverse events associated with the DT-PLB intervention
In each DT-PLB session, the participants during the intervention will record whether they had any uncomfortable feelings
Immediately after completion of the 8-week intervention
Secondary Outcomes (7)
mMRC Dyspnea Scale
From baseline (T1) to the completion of the 8-week intervention (T2)
CAT scale
From baseline (T1) to the completion of the 8-week intervention (T2)
The System Usability Scale
Immediately after completion of the 8-week intervention (T2)
Participants overall satisfaction
Immediately after completion of the 8-week intervention (T2)
Six-minute-walking test
From baseline (T1) to the completion of the 8-week intervention (T2)
- +2 more secondary outcomes
Study Arms (1)
Digital PLB intervention
EXPERIMENTALParticipants will perform the following tasks during the intervention: 1. Register a personal account on the theory-based pursed lip breathing intervention protocol software system installed on smartphones(DT-PLB). 2. Acquire knowledge and skills related to pursed lip breathing by watching instructional videos. 3. Practice Pursed Lip Breathing for 10 minutes per session, three times daily for eight weeks, as per reminders and guidance provided by the software. 4. Earn health points by completing specific actions as instructed. 5. Optionally post individual texts on the peer forum for peer support within the DT-PLB software. 6. Complete two outcome assessments as scheduled.
Interventions
After registration, participants will watch an educational video on the developed software, covering the definition, benefits, and techniques of pursed lip breathing. Following this, participants will engage in pursed lip breathing interventions, guided by voice and animated instructions from the software. These sessions will occur three times daily (morning, afternoon, and night) for 10 minutes each, lasting for 8 weeks. After each session, participants can choose to post texts on a peer social forum for peer support. Fellow participants can give 'comments' or 'likes'. The principal researcher will oversee texts, peer comments, removing information containing personal data, medical recommendations, and negative comments. Additionally, participants can earn health points by performing specific actions (e.g., watching the educational video and practicing pursed lip breathing) on the software, encouraging their participation in related activities.
Eligibility Criteria
You may qualify if:
- Diagnosed with COPD satisfying GOLD criteria (Agusti, 2022) ;
- Being Chinese;
- Able to understand, speak, and hear;
- Clinically stable for at least three months prior to enrollment (Soler-Cataluna et al., 2018) ;
- The classification of GOLD grades for patients is mild, moderate, and severe, which means: FEV1/FVC\<70%, FEV1\>30%pre (Agusti, 2022) ;
- Participants who were mindful about the IT technology and known how to use a smartphone.
You may not qualify if:
- Impaired hand function causing inability to use the application;
- Have disorders in pleural effusion, pulmonary malignancy, heart diseases, stroke with sequels;
- Patients who have oral or nasal diseases cannot complete the exercise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, 646000, China
Related Publications (1)
Huang H, Liu F, Mohammad M, Watson R, Hayter M, Huang M, Li Z. Digital gamification-based pursed lip breathing exercises driven by Behaviour Change Wheel in patients with COPD: a feasibility trial protocol using pre-post study design. BMJ Open. 2025 Mar 27;15(3):e090832. doi: 10.1136/bmjopen-2024-090832.
PMID: 40147988DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Houqiang Huang, Master
Manchster Metropolitan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- A postgraduate researcher in the School of Nursing & Public Health
Study Record Dates
First Submitted
September 22, 2023
First Posted
October 2, 2023
Study Start
October 30, 2023
Primary Completion
April 20, 2024
Study Completion
April 20, 2024
Last Updated
October 2, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share